NASDAQ$ASTH
Astrana Health Inc · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
Apollo Medical Holdings reported record revenue and net income growth for 2020, beating annual guidance.
ApolloMed announced its consolidated financial results for the fourth quarter and year ended December 31, 2020, achieving record top and bottom line growth due to the NGACO's performance, acquisitions, decreased utilization, and increased operational efficiencies.
- ApolloMed achieved record top and bottom line growth in 2020.
- The company benefited from its NGACO's performance and acquisitions.
- Decreased utilization and increased operational efficiencies contributed to growth.
- ApolloMed announced a strategic investment and alliance with CAIPA MSO in New York.
Headline financials
Revenue & EPS history
Astrana Health · Revenue · Quarterly
$39.7M
Forward guidance
ApolloMed provided guidance for total revenue, net income, EBITDA, and Adjusted EBITDA for the year ending December 31, 2021, based on existing business and market conditions.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2020
+0.7%
Avg return
Earnings day
-2.1%
Avg return
5 days after
+2.1%
Avg return
30 days after
40%
23 / 57 earnings
Positive
+83.3%
Q3 2011
Best reaction
-40.5%
Q2 2012
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | +29.4% | +22.5% | +20.6% | |
| Q3 2025 | -23.4% | -29.4% | -33.8% | |
| Q1 2025 | -11.1% | -20.8% | -24.5% | |
| Q4 2024 | -26.8% | +5.0% | +16.1% | |
| Q3 2024 | -21.1% | -27.9% | -30.4% | |
| Q2 2024 | -1.4% | -1.8% | +0.1% | |
| Q1 2024 | -0.7% | +1.5% | +8.0% | |
| Q4 2023 | +2.3% | +1.8% | -1.9% | |
| Q3 2023 | +9.3% | +2.9% | +13.4% | |
| Q2 2023 | +4.2% | +3.5% | -17.4% | |
| Q1 2023 | +5.4% | +7.0% | -0.8% | |
| Q4 2022 | +6.9% | +5.2% | +15.2% | |
| Q3 2022 | +8.4% | +8.9% | -14.5% | |
| Q2 2022 | -4.3% | -11.0% | -29.3% | |
| Q1 2022 | -0.5% | -5.4% | -26.4% | |
| Q4 2021 | -2.0% | -11.0% | -7.0% | |
| Q3 2021 | +14.7% | +30.5% | +0.8% | |
| Q2 2021 | -11.8% | -10.7% | -12.9% | |
| Q1 2021 | +4.5% | +4.7% | +10.9% | |
| Q4 2020 | +9.1% | +8.8% | +8.3% | |
| Q3 2020 | -1.2% | -1.6% | +0.5% | |
| Q2 2020 | +1.8% | +2.4% | +7.9% | |
| Q1 2020 | -10.4% | -11.6% | +13.1% | |
| Q4 2019 | -12.9% | -24.0% | +7.0% | |
| Q3 2019 | -2.9% | -0.9% | +25.0% | |
| Q2 2019 | -5.0% | +4.8% | +31.1% | |
| Q1 2019 | -1.2% | -4.3% | -29.7% | |
| Q4 2018 | -6.4% | -8.3% | -6.9% | |
| Q3 2018 | +26.3% | +4.0% | -4.6% | |
| Q2 2018 | -13.7% | -23.3% | -32.2% | |
| Q4 2017 | +10.8% | -6.3% | +2.1% | |
| Q1 2018 | +10.8% | -6.3% | +2.1% | |
| Q3 2017 | +3.9% | +3.9% | +140.0% | |
| Q2 2017 | +0.0% | +0.0% | -10.5% | |
| Q1 2017 | +0.0% | +6.7% | +36.7% | |
| Q1 2016 | +4.0% | +4.0% | +0.0% | |
| Q3 2016 | -4.8% | — | — | |
| Q2 2016 | -12.9% | — | — | |
| Q1 2015 | -6.5% | — | — | |
| Q3 2015 | -3.2% | — | — | |
| Q2 2015 | +0.0% | — | — | |
| Q2 2014 | +15.6% | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | +1.6% | — | — | |
| Q2 2013 | +13.5% | — | — | |
| Q1 2013 | -13.3% | — | — | |
| Q4 2012 | -2.2% | — | — | |
| Q3 2012 | -9.1% | — | — | |
| Q2 2012 | -40.5% | — | — | |
| Q1 2012 | +0.0% | — | — | |
| Q4 2011 | — | — | — | |
| Q3 2011 | +83.3% | — | — | |
| Q2 2011 | +0.5% | — | — | |
| Q1 2011 | -0.5% | — | — | |
| Q4 2010 | -3.9% | — | — | |
| Q3 2010 | +19.0% | — | — | |
| Q2 2010 | +0.0% | — | — | |
| Q1 2010 | -2.1% | — | — | |
| Q4 2009 | +9.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro